A carregar...
Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations
BACKGROUND: Antibiotic innovation has dwindled to dangerously low levels in the past 30 years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients. A number of new incentives have been suggested to stimulate greater antibacterial drug innovation....
Na minha lista:
| Publicado no: | J Pharm Policy Pract |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885303/ https://ncbi.nlm.nih.gov/pubmed/29632669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-018-0135-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|